Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| WINDACRE PARTNERSHIP LLC | VSXY Victoria's Secret & Co. | 13G/A | 7.22% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | AREB American Rebel Holdings Inc | 13G | 7.42% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | REVG REV Group, Inc. | 13G/A | 3.4% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | AIRJ AirJoule Technologies Corp. | 13G | 9.61% | Dec 31, 2023 | 2y |
| Dragoneer Investment Group, LLC | NCNO nCino, Inc. | 13G/A | 4.1% | Dec 31, 2023 | 2y |
| Millennium Management LLC | PLMJF Plum Acquisition Corp. III | 13G/A | 8.5% | Dec 31, 2023 | 2y |
| Thomas Caleca | KSCP Knightscope, Inc. | 13G/A | 1.46% | Dec 31, 2023 | 2y |
| GREAT POINT PARTNERS LLC | ALPN Alpine Immune Sciences, Inc. Common Stock | 13G/A | 6.37% | Dec 31, 2023 | 2y |
| Mary Sue Robinson Morrill | SCHL Scholastic Corp | 13G | 9.4% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | ICVX Icosavax, Inc. Common Stock | 13G | 7.8% | Dec 31, 2023 | 2y |
| JAT Capital Mgmt LP | NXH Neighborhood Intelligence, Inc. | 13G/A | 9.2% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | APCA AP Acquisition Corp | 13G | 9.88% | Dec 31, 2023 | 2y |
| HGC Investment Management Inc. | KDK Kodiak AI, Inc. | 13G | 9.76% | Dec 31, 2023 | 2y |
| SYLEBRA CAPITAL LLC | CHGG Chegg, Inc | 13G | 8.13% | Dec 31, 2023 | 2y |
| LUCERNE CAPITAL MANAGEMENT LP | ADSE Ads-Tec Energy Public Ltd Co | 13G/A | 10.3% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | PPHP PHP Ventures Acquisition Corp. Class A Common Stock | 13G | 6.3% | Dec 31, 2023 | 2y |
| Jericho Capital Asset Management L.P. | MSGE Madison Square Garden Entertainment Corp. | 13G | 5.6% | Dec 31, 2023 | 2y |
| Commodore Capital LP | ELVN Enliven Therapeutics, Inc. | 13G/A | 7% | Dec 31, 2023 | 2y |
| Crestview Partners II GP, L.P. | VCTR Victory Capital Holdings, Inc. | 13G/A | 17.6% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | RCAC Revelstone Capital Acquisition Corp. Class A Common Stock | 13G | 8.09% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | BRLS Borealis Foods Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Fairmount Funds Management LLC | ATXS Astria Therapeutics, Inc. Common Stock | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | AMAM Ambrx Biopharma, Inc. Common Stock | 13G/A | 3.3% | Dec 31, 2023 | 2y |
| Almitas Capital LLC | DMA Destra Multi-Alternative Fund | 13G | 5.04% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | CPTAF Captivision Inc. | 13G/A | 2.08% | Dec 31, 2023 | 2y |
| AdvisorShares Trust | CMND Clearmind Medicine Inc. | 13G | 5.48% | Dec 31, 2023 | 2y |
| Shay Capital LLC | TBCH Turtle Beach Corp | 13G/A | 4.96% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | VEEE Twin Vee PowerCats, Co. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | PHYT Pyrophyte Acquisition Corp. | 13G | 5.85% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | NRIX Nurix Therapeutics, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | FLD Fold Holdings, Inc. | 13G | 7.53% | Dec 31, 2023 | 2y |
| COHEN & STEERS, INC. | KIM Kimco Realty Corp | 13G/A | 7.26% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | TGVC TG Venture Acquisition Corp. Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| HSG Holding Ltd | THCH TH International Ltd | 13G/A | 9.2% | Dec 31, 2023 | 2y |
| Hood River Capital Management LLC | APLD Applied Digital Corp. | 13G | 8.08% | Dec 31, 2023 | 2y |
| Aaron Rollins | AIRS Airsculpt Technologies, Inc. | 13G/A | 24.99% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | BCOW 1895 Bancorp of Wisconsin, Inc. | 13G/A | 10% | Dec 31, 2023 | 2y |
| Fourthstone LLC | CVLY Codorus Valley Bancorp Inc | 13G/A | 6.99% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | SUPN Supernus Pharmaceuticals, Inc. | 13G/A | 8.51% | Dec 31, 2023 | 2y |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | TCRT Alaunos Therapeutics, Inc. | 13G/A | 1.66% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | JANX Janux Therapeutics, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Caledonia (Private) Investments Pty Ltd | GENI Genius Sports Ltd | 13G/A | 9.82% | Dec 31, 2023 | 2y |
| HHLR ADVISORS, LTD. | EM Smart Share Global Ltd | 13G/A | 14% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | OEC Orion S.A. | 13G | 5% | Dec 31, 2023 | 2y |
| AVENIR CORP | CTSO Cytosorbents Corp | 13G | 6.87% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | AAP Advance Auto Parts Inc | 13G/A | 5.9% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | FBP First Bancorp | 13G/A | 5% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | FITB Fifth Third Bancorp | 13G/A | 6.2% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | BWAY Brainsway Ltd. | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | AIZ Assurant, Inc. | 13G/A | 9.7% | Dec 31, 2023 | 2y |